What is Vor Biopharma's fair value adjustment of warrants?

Vor Biopharma (VOR) reported fair value adjustment of warrants of $188.36M in Q1 2026.

What does fair value adjustment of warrants mean?

This reflects the periodic non-cash gain or loss resulting from the revaluation of outstanding warrant liabilities to their current market value. It indicates the impact of market volatility on the company's balance sheet and financial results.

Vor Biopharma VOR Fair Value Adjustment Of Warrants

Fair Value Adjustment Of Warrants at other companies

PureCycle Technologies, Inc.PCT

-$23M+59.4%

NextNavNN

-$3.43M+43.2%

SOC

Sable Offshore Corp.SOC

$44.16M+107%

Falcon's Beyond GlobalFBYD

$0+100%

Taysha Gene Therapies, Inc.TSHA

$736K+987%

IBT

IbottaIBTA

$2.16M0.0%

Other financials

Income statement

See full

Operating income-$35.2M-5.6%

Net income-$219.6M-576%

EPS (diluted)-$5.11+1.9%

Balance sheet

See full

Cash & equivalents$169.9M+239%

Total debt$2.9M-90.5%

Total equity-$150.4M-328%

Total assets$506.7M+364%

Cash flow

See full

Operating cash flow-$38.2M-23.1%

CapEx$48.0K-79.2%

Free cash flow-$38.3M-22.4%

Valuation

See full

Market cap$784.61M+2,594%

Enterprise value$617.68M+5,866%

Returns & leverage

See full

Return on equity-125.4%+671pp

Debt / equity0.5×+0.2×

Current ratio31.1×+27.3×

Where this comes from

Reported directly by Vor Biopharma in its filing.

Tagged under the XBRL concept us-gaap:FairValueAdjustmentOfWarrants.

The official record: Vor Biopharma’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vor Biopharma's fair value adjustment of warrants.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Vor Biopharma's fair value adjustment of warrants?: Vor Biopharma (VOR) reported fair value adjustment of warrants of $188.36M in Q1 2026.
What does fair value adjustment of warrants mean?: This reflects the periodic non-cash gain or loss resulting from the revaluation of outstanding warrant liabilities to their current market value. It indicates the impact of market volatility on the company's balance sheet and financial results.